Select Page

Home / Share Price Target / Pghl

Procter & Gamble Health Share Price Target 2024, 2025, 2026 to 2039 With Charts

Procter & Gamble Health Limited

Company LogoSymbol: PGHL
Price: ₹5,148.35
Exchange: NSE
Healthcare -> Drug Manufacturers - Specialty & Generic
Show Table of Contents

Procter & Gamble Health Brief Company Overview

Procter & Gamble Health Limited: A Global Healthcare Pioneer

Established in 1967, Procter & Gamble Health Limited (formerly Merck Limited) is a leading manufacturer and marketer of pharmaceuticals and chemical products in India and worldwide. Headquartered in Mumbai, the company boasts a diverse product portfolio.

Key Products and Services:
  • Over-the-counter products
  • Vitamins, minerals, and supplements
Market Presence:Procter & Gamble Health Limited has a strong presence in the healthcare industry, with its products available in multiple countries.Reputation and Commitment:The company is renowned for its high-quality products and commitment to improving health outcomes. Procter & Gamble Health Limited's mission is to "make a meaningful difference in the lives of our consumers by providing them with innovative and affordable healthcare solutions."

Advertisement

Procter & Gamble Health Financial Performance

MetricValueDescription
Market Capital7,955.26 CroreMarket valuation of Procter & Gamble Health's shares.
Revenue (TTM)1,168.56 CroreTotal revenue generated by Procter & Gamble Health over the past twelve months.
Net Income (TTM)+214.01 CroreNet Profit or Loss after all the expenses over the past twelve months.
Operating Margin25.02%Income from operations as a percentage of revenue, before taxes and interest.
Profit Margin18.31%Net income as a percentage of revenue, after all expenses.
Revenue Growth
(Quarterly)
-21.3%Change in revenue compared to the previous quarter.
Earnings Growth
(YOY Quarterly)
-21.3%Change in earnings compared to the same quarter last year.
Debt-to-Equity
(D/E) Ratio
1.34Company's total debt divided by total shareholder equity.
Total Debt10.8 CroreSum of Procter & Gamble Health's current & long-term financial obligations.
Total Cash425.56 CroreTotal amount of liquid funds available to Procter & Gamble Health.
Beta0.44Beta is less than 1 indicating that the Procter & Gamble Health's price is less volatile than the market.

Is Procter & Gamble Health A Good Buy For Long Term?

Procter & Gamble Health is a midcap stock with a moderate market capitalization. Over the past year, the company has seen a decline in earnings and revenue growth. However despite this, it maintains a healthy profit margin of 18.31%. Financially, the company has a manageable debt of 10.8 Crore and a strong cash balance of 425.56 Crore. Considering these factors, Procter & Gamble Health may be considered an average buy for long-term investment, with potential for future growth.

To predict the Procter & Gamble Health's future market prices, we harnessed 2 dynamic approaches:

Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices

Approach 1: Technical Analysis Paired With Price Action

Procter & Gamble Health Share Price Target For 2024

Procter & Gamble Health Targets For 2024 Chart

The line chart displays the monthly closing prices of Procter & Gamble Health with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.

For detailed target and stop loss values for Procter & Gamble Health shares in 2024, see the table below.

Advertisement

Procter & Gamble Health Share Price Target Table For 2024

Procter & Gamble Health's LevelsValueReason/Importance
2024 Target 35289.25 (+2.73%)Fibonacci Extension Level 100%
2024 Target 25232.45 (+1.63%)Price Action: 04 Nov 2024 Low
2024 Target 15175.00 (+0.51%)Price Action: 01 Nov 2024 Low
Current Price5148.35Procter & Gamble Health's 1 share price as of Thu 14 Nov 2024
Stop Loss 15137.16 (-0.22%)Fibonacci Retracement Level 98.6%
Stop Loss 25073.30 (-1.46%)Fibonacci Retracement Extended 40%
Stop Loss 35015.45 (-2.59%)Price Action: 30 Oct 2024 Low

Summary: Procter & Gamble Health Share Price Prediction For 2024

In summary, Procter & Gamble Health has surged by ₹200.60, achieving a notable +4.05% increase from 1st January 2024 to 14 Nov 2024. Our analysis of Procter & Gamble Health for 2024 predicts an additional rise of 0.51% to 2.73% by the end of 2024 with three potential targets T1: 5175.00, T2: 5232.45, T3: 5289.25. Stop Loss at SL1: 5137.16, SL2: 5073.30, SL3: 5015.45.

Procter & Gamble Health has a 52-week high of ₹5833.29, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹4636.54, a critical support level - think of this as a safety net where the price might stop falling.

After looking at 2024's share price prediction, let's now check what 2025 might hold for Procter & Gamble Health.

Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!

Join our WhatsApp group

Join our Telegram group

Your phone number will be HIDDEN to other users.

Procter & Gamble Health Share Price Target For 2025

Procter & Gamble Health Targets For 2025 Chart

The line chart displays the monthly closing prices of Procter & Gamble Health with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.

For detailed target and stop loss values for Procter & Gamble Health shares in 2025, see the table below.

Advertisement

Procter & Gamble Health Share Price Target Table For 2025

Procter & Gamble Health's LevelsValueReason/Importance
2025 Target 35958.06 (+15.72%)Custom Fibonacci Extension Lvl 82%
2025 Target 25855.92 (+13.74%)Price Action: Jun 2021 High
2025 Target 15754.31 (+11.76%)Price Action: Oct 2021 High
Current Price5148.35Procter & Gamble Health's 1 share price as of Thu 14 Nov 2024
Stop Loss 15001.10 (-2.87%)Price Action: Jun 2024 Low
Stop Loss 24951.00 (-3.84%)Price Action: 28 Oct 2024 Low
Stop Loss 34900.00 (-4.83%)Price Action: Oct 2023 Low

Summary: Procter & Gamble Health Share Price Prediction For 2025

In summary, Procter & Gamble Health has surged by ₹200.60, achieving a notable +4.05% increase from 1st January 2024 to 14 Nov 2024. Our analysis of Procter & Gamble Health for 2025 predicts an additional rise of 11.76% to 15.72% by the end of 2025 with three potential targets T1: 5754.31, T2: 5855.92, T3: 5958.06. Stop Loss at SL1: 5001.10, SL2: 4951.00, SL3: 4900.00.

Procter & Gamble Health has a All-Time high of ₹7500.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹4636.54, a critical support level - think of this as a safety net where the price might stop falling.

After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Procter & Gamble Health, we have created a specific page for that check here: Procter & Gamble Health Share Price Target For Tomorrow & Next Week

Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!

Join our WhatsApp group

Join our Telegram group

Your phone number will be HIDDEN to other users.

Approach 2: Machine Learning By Studying Historical Prices

Procter & Gamble Health Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039

Procter & Gamble Health Targets Chart 2024, 2025, 2026 to 2039

This chart presents a detailed projection of Procter & Gamble Health share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 2.3% over the next 15 years.

For complete year by year Procter & Gamble Health long term share price target from 2024, 2025 to 2039 check the below table.

Procter & Gamble Health Share Price Target Table From 2024, 2025, 2026 to 2039

YearProcter & Gamble Health TargetYoY Change %
2024₹5,148.35[Current Price]
2024₹5,224.241.47%
2025₹5,427.073.88%
2026₹5,606.583.3%
2027₹5,488.96-2.1%
2028₹5,475.13-0.26%
2029₹5,9739.09%
2030₹6,183.233.51%
2031₹6,366.562.96%
2032₹6,213.36-2.41%
2033₹6,179.13-0.56%
2034₹6,721.778.78%
2035₹6,939.383.23%
2036₹7,126.552.69%
2037₹6,937.77-2.65%
2038₹6,883.13-0.79%
2039₹7,187.154.41%

Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!

Join our WhatsApp group

Join our Telegram group

Your phone number will be HIDDEN to other users.

Procter & Gamble Health Past Performance

PGHL main
Procter & Gamble Health has been listed on NSE for more than 34 years.
  • In 1990, Procter & Gamble Health opening price was ₹50.83
  • As of Thu 14 Nov 2024 the price stands at ₹5,148.35.
  • This represents a Compound Annual Growth Rate (CAGR) of 14.1%.
  • In 34 years, an investment of 10,000 would have become ₹10.12 Lakh.

As we wrap up, we hope you like our study on Procter & Gamble Health share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.

Show Methodology We Use

Methodology Behind the Prediction

The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.

We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.

For more insights into Procter & Gamble Health Limited, explore these additional resources:-

Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.

About The Author

Nippun

Hi, I’m Nippun, a tech enthusiast from Haryana, India. I have been coding since 2010 and using my coding skills in the share market since 2020. I have been coding scripts in Pinescript that work on Tradingview app/web. I love learning about new technology and applying it to solve real-world problems. Coding and share-market are my passions, and I enjoy finding and fixing bugs in code. I aim to share my skill set and experience that can positively impact society. Feel free to connect with me, and let’s learn from each other. My Twitter